Neonatal vaccination of low birthweight infants in Ghana

Maureen O'Leary1, Karen Edmond2, Sian Floyd1

  • 1Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.

Insights

Low birth weight (LBW) infants are significantly underserved by neonatal BCG vaccination, highlighting a critical gap in global immunization equity. Improving vaccination practices at healthcare facilities is essential for timely and equitable BCG coverage.

Area of Science:

  • Public Health
  • Immunology
  • Neonatal Care

Background:

  • Global vaccination policies aim to enhance equity and uptake by identifying underserved populations.
  • Neonatal BCG vaccination is crucial for protecting infants against severe forms of tuberculosis.
  • Understanding determinants of vaccination is key to improving coverage, especially for vulnerable infants.

Purpose of the Study:

  • To investigate birth weight as a determinant of neonatal BCG vaccination.
  • To identify infants underserved by neonatal BCG vaccination.
  • To assess the impact of place of delivery and infant illness on BCG vaccination disparities.

Main Methods:

  • Logistic regression analysis was used to calculate adjusted odds ratios (AORs).
  • Association between low birth weight (LBW) categories and non-vaccination with BCG was examined.
  • Data included birth weight, place of delivery, infant illness, and BCG vaccination status up to 27 days.

Main Results:

  • A significant dose-response relationship exists between LBW and delayed/missed neonatal BCG vaccination (p-trend<0.0001).
  • Infants weighing 1.50-1.99 kg (AOR 1.64) and <1.50 kg (AOR 2.42) had higher odds of non-vaccination compared to non-LBW infants.
  • Facility-born infants received BCG vaccination at a mean of 6 days, indicating delayed vaccination post-discharge.

Conclusions:

  • Low birth weight is a significant risk factor for under-vaccination in the neonatal period, even for facility-born infants.
  • Ensuring BCG vaccination at the time of facility birth would substantially improve vaccination timing and equity.
  • Targeting LBW infants and improving in-facility vaccination protocols are crucial for equitable BCG coverage.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...